Antibiotic receipt by respiratory symptom group and source of care among children under five in Bangladesh: repeated cross-sectional analyses of national surveys, 2019 and 2025
Background: Antibiotic use for childhood respiratory illness is common in low-income and middle-income countries, but national surveys rarely separate symptom groups or care pathways. We estimated antibiotic receipt among children under five in Bangladesh by reported respiratory symptom group, source of care and household wealth. Methods: We analysed the 2019 and 2025 Bangladesh Multiple Indicator Cluster Surveys. We included 4,010 children with cough and difficult breathing in the previous two weeks (3,990 in regression models). We compared breathing difficulty from the chest (suspected pneumonia) with nose-only symptoms, and five reported sources of care. Survey-weighted modified Poisson regression estimated adjusted prevalence ratios (PRs). We described where antibiotic-treated children sought care and estimated slope indices of inequality (SIIs) by wealth. Results: In 2025, 68.5% (95% CI 64.2 to 72.5) of children with suspected pneumonia received an antibiotic, as did 54.3% (51.3 to 57.2) of children with nose-only symptoms. In pooled analyses of both surveys, the adjusted PR for nose-only symptoms was 0.83 (0.78 to 0.89). Against public health care, the pooled adjusted PR was 0.98 (0.91 to 1.07) for pharmacy care without a medical facility. It was 0.24 (0.20 to 0.29) for no advice or treatment sought. Pharmacy care rose from 18.8% to 36.5% of children with cough and difficult breathing between 2019 and 2025. By 2025, it accounted for 43.7% of treated children with suspected pneumonia and 42.2% with nose-only symptoms. Across the pooled surveys, receipt for suspected pneumonia was higher in richer children (SII 12.5 percentage points, 1.0 to 24.0). Recorded amoxicillin receipt in suspected pneumonia was 17.7% (14.7 to 21.1) in 2025, with no clear wealth gradient. Conclusions: Antibiotic receipt was common in both symptom groups, and care contacts shifted towards pharmacies. Receipt and care seeking differed by wealth. Antibiotic receipt should be monitored alongside symptoms and care contacts. Stewardship should be evaluated in medical and pharmacy settings while protecting access to assessment and appropriate treatment. The surveys cannot determine whether individual courses were appropriate.
Authors
- Kamran Ul Baset (ORCID: https://orcid.org/0000-0001-8701-2618)
- Mohammad Khalid Hasan (ORCID: https://orcid.org/0009-0001-6896-0767)
- S. M. Raysul Haque (ORCID: https://orcid.org/0000-0002-8963-6907)
- Fariha Haseen (ORCID: https://orcid.org/0000-0001-5369-573X)
- Khairul Islam (ORCID: https://orcid.org/0000-0001-8871-6270)
- Ashika Sultana (ORCID: https://orcid.org/0009-0001-4857-5378)
- S.M. Ashraf Ul Hoque (ORCID: https://orcid.org/0009-0000-4735-0989)
- Tanvir Ahmed
Institutions
- Bangladesh Medical University (BD)
- Independent University, Bangladesh (BD)
- Dhaka Medical College and Hospital (BD)
Publication Details
- Journal
- medRxiv
- Published
- 2026-11-12
- DOI
- https://doi.org/10.64898/2026.11.11.26367825
- Primary Topic
- Antibiotic Use and Resistance
- Type
- preprint